Michael Helmrath · Intestinal rehabilitation in pediatric short bowel syndrome: expert strategies for autonomy
Podcast12 min·Published Jun 2024Older

Intestinal rehabilitation in pediatric short bowel syndrome: expert strategies for autonomy

With Dr. Paul Well & Dr. Michael Helmrath

Chapter 1 of 7

Introduction

Introduction and webinar context

Try
Intelligent Search· scoped to short bowel syndrome · not medical adviceSearch the whole library →
What the experts said27 expert statements
Young infants, babies, infants, and young children have tremendous gut growth potential, with the gut growing for the first several years of life.
ClinicalPaul Well
Residual bowel should be discussed as a percentage of what is normal for a child of that age, not in absolute centimeters.
ClinicalPaul Well
A term baby will have 160 centimeters of small bowel, and by the time the child is 5 years old, it almost triples to about 425 to 450 centimeters.
ClinicalPaul Well
A patient can achieve enteral autonomy with as low as 10% expected gut length if they have the majority of their colon in continuity.
ClinicalPaul Well
The more important factor is the presence or absence of the distal small bowel or ileum and right colon that can act as a reclamation of bile and support the enterohepatic circulation.
ClinicalMichael Helmrath
The distal ileum produces hormones and incretins like GLP-2, GLP-1, and PYY.
ClinicalMichael Helmrath
The importance is not the ileocecal valve itself, but rather the distal ileum and proximal colon where bile recirculation occurs and hormones that help intestinal growth and absorption are produced.
OpinionMichael Helmrath
The strategy at the first operation should provide a pathway forward that allows early enteral feeding, and it is sometimes better to stage reconstruction under more controlled conditions.
ClinicalMichael Helmrath
In situations of overwhelming intestinal loss, the strategy is to provide proximal control that allows feeding to occur without the enteral stream going through, and to leave questionable bowel with the understanding that many segments deemed non-usable have potential to heal.
ClinicalMichael Helmrath
As long as proximal diversion is achieved and the baby is stable, questionable bowel can be left for potential use in later secondary reconstructive procedures.
Clinical
The overarching principle is to deliver adequate nutrition to have normal growth within normal parameters, ideally enterally.
ClinicalPaul Well
As much as possible, the goal is to establish normal feeding behavior, recognizing that enteral nutrition is more than just nutrition.
ClinicalPaul Well
If a patient needs tube support from the beginning, bolus feeding should be tried rather than defaulting to continuous feeding.
ClinicalPaul Well
When motility issues or delayed gastric emptying prevent tolerance of food into the stomach, the strategy is to feed beyond the stomach and decompress the stomach through an NG tube if the child fails both bolus and continuous gastric feeding.
ClinicalPaul Well
Breast milk is the formula of choice, not only for its nutritional benefits but for all the other beneficial components within breast milk.
ClinicalMichael Helmrath
Formulas can be categorized as intact formulas or semi-elemental/elemental formulas, with protein and fat modules being particularly important.
ClinicalPaul Well
Single amino acid level protein is the generalized preference, ensuring patients are not having high stool output, high fluid losses, wound breakdown, rashes, or emesis.
ClinicalMichael Helmrath
Long chain fat is the preferred fat module rather than MCT fat, even though there is a feeling that MCT fat is better tolerated in short bowel syndrome.
OpinionPaul Well
Long chain fat is a much stronger stimulus for GLP-2 release compared to MCT, which is important when trying to drive adaptation.
ClinicalPaul Well
Not every child needs to be on SMOFlipid for parenteral nutrition.
OpinionPaul Well
For preterm babies, SMOFlipid is not the ideal lipid emulsion but is the best currently available option.
OpinionPaul Well
SMOFlipid does not have enough arachidonic acid, which is important for brain development.
ClinicalPaul Well
There are two strategies to treat cholestasis: reduce the total amount of fat or change the composition to introduce SMOFlipid or omegaven.
Clinical
Reducing lipid dose to 1 g per kg per day can reverse cholestasis but results in reduced calorie delivery that can impair growth and potentially impact neurocognitive development.
Clinical
Omegaven is essentially pure fish oil with omega-3 and is dosed at 1 g/kg, so babies take a calorie deficit.
Clinical
SMOFlipid is a better choice than omegaven as it is a more well-balanced emulsion with an omega-3 to omega-6 ratio of 2.5 to 1, is less inflammatory than intralipid, and promotes bile flow.
Opinion
SMOFlipid should not be restricted and must be given at no less than 2 or 2.1 g per kg per day.
Clinical